Nipping Alzheimer’s disease in the blood

Possible breakthrough approach to preventing Alzheimer’s disease

Richard Asinof, ConvergenceRI
Posted 10/17/22

MindImmune, a drug discovery firm at the University of Rhode Island, is poised to move into clinical trials, pioneering a breakthrough approach to preventing Alzheimer’s disease, focused on blocking aberrant immune cells in the blood from entering the brain

This item is available in full to subscribers.

Please log in to continue

Username
Password
Log in

Don't have an ID?


Print subscribers

If you're a print subscriber, but do not yet have an online account, click here to create one.

Non-subscribers

Click here to see your options for becoming a subscriber.

If you made a voluntary contribution in 2021-2022, but do not yet have an online account, click here to create one at no additional charge. VIP Digital Access includes access to all websites and online content.


Our print publications are advertiser supported. For those wishing to access our content online, we have implemented a small charge so we may continue to provide our valued readers and community with unique, high quality local content. Thank you for supporting your local newspaper.
Our Papers

Ad blocker detected

We have noticed you are using an ad blocking plugin in your browser.

The revenue we receive from our advertisers helps make this site possible. We request you whitelist our site.